Araştırma Makalesi


DOI :10.26650/IstanbulJPharm.2022.959603   IUP :10.26650/IstanbulJPharm.2022.959603    Tam Metin (PDF)

An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats

Asha ThomasSeema KambleSohan ChitlangeArchana K. Thikekar

Background and Aims: Tinospora cordifolia (Willd.) Miers (TC), from the Menispermaceae family, is a well-known traditional herb used to treat diabetes mellitus and a variety of other ailments, according to traditional Indian literature. Herbal treatments are commonly used as alternatives to medicines. Anti-diabetic herbal medicines containing TC are available in the market. TC has been identified as a powerful CYP2C9 inhibitor, boosting the risk of herb-drug interactions (HDI) when used with medications metabolized via the CYP pathway. The present study evaluated the pharmacokinetic HDI of TC extract with Gliclazide (GL) after oral co-administration in Wistar rats using in vivo pharmacokinetic studies. Methods: A simple, sensitive & accurate RP-HPLC/PDA method was developed and validated. Chromatographic separations were performed on a C18 analytical column with a mobile phase of acetonitrile and 40 mM ammonium acetate buffer (55:45 v/v) pH 3.0 and flow rate gradient programming. The drug concentrations in plasma were measured using the RP-HPLC method after oral co-administration of TC extract (100 mg/kg) with GL (8.3 mg/kg) in Wistar rats. Results: The pharmacokinetic (PK) interaction studies showed that the bioavailability of GL had significantly increased, with a significant influence on Cmax, AUC0-48, and suppression of volume of distribution (Vd), with no change in Tmax. Conclusion: The results obtained from this in vivo study proposed that there is a potentially significant PK HDI when GL and TC extract are administered together. This knowledge of potential HDI could be beneficial to healthcare providers and diabetic patients on GL medication. Further research is needed to anticipate this pharmacokinetics HDI of GL in humans.


PDF Görünüm

Referanslar

  • Adhikari, L., Mishra, U. S., & Murthy, P. N. (2014). RP-HPLC deter-mination of gliclazide in rat plasma and its application in phar-macokinetic studies. International Journal of PharmTech Research, 6(2), 692-700. google scholar
  • Bahadur, S., Mukherjee, P., Milan Ahmmed, S., Kar, A., Harwansh, R., &Pandit, S. (2016). Metabolism-mediated interaction potential of standardized extract of Tinospora cordifolia through rat and human liver microsomes. Indian Journal of Pharmacology, 48(5), 576-581. https://doi.org/10.4103/0253-7613.190758 google scholar
  • Brantley, S. J., Argikar, A. A., Lin, Y. S., Nagar, S., & Paine, M. F. (2014). Herb-drug interactions: Challenges and opportunities for im-proved predictions. Drug Metabolism and Disposition, 42(3), 301317. https://doi.org/10.1124/dmd.113.055236 google scholar
  • Chatterjee, P., & Franklin, M. R. (2003). Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 31(11), 1391-1397. https://doi.org/10.1124/dmd.31.11.1391 google scholar
  • Choudhary, N., Siddiqui, M. B., & Khatoon, S. (2014). Pharmacog-nostic evaluation of Tinospora cordifolia (Willd.) Miers and iden-tification of biomarkers. Indian Journal of Traditional Knowledge, 13(3), 543-550. google scholar
  • Fugh-Berman, A., & Ernst, E. (2001). Herb-drug interactions: re-view and assessment of report reliability. British Journal of Clinical Pharmacology, 52(5), 587-595. https://doi.org/10.1046/j.0306-5251.2001.01469.x google scholar
  • Hu, Z., Yang, X., Ho, P. C. L., Chan, S. Y., Heng, P. W. S., Chan, E., Duan, W., Koh, H. L., & Zhou, S. (2005). Herb-drug interac-tions: a literature review. Drugs, 65(9), 1239-1282. https://doi. org/10.2165/00003495-200565090-00005 google scholar
  • Kuo, C.-Y., & Wu, S.-M. (2005). High-performance liquid chroma-tography with electrochemical detection for analysis of gliclazide in plasma. Journal of Chromatography. A, 1088(1-2), 131—135. https://doi.org/10.1016/j.chroma.2004.12.097 google scholar
  • Meshram, A., Bhagyawant, S., Gautam, S., & Srivastava, N. (2013). Potential role of Tinosporacordifolia in pharmaceuticals. World Journal of Pharmaceutical Sciences, 2, 4615-4625. google scholar
  • Posadzki, P., Watson, L., & Ernst, E. (2013). Herb-drug interac-tions: an overview of systematic reviews. British Journal of Clinical Pharmacology, 75(3), 603-618. https://doi.org/10.1111/j.1365-2125.2012.04350.x google scholar
  • Prabhakar, P. K., &Doble, M. (2008). A target based thera-peutic approach towards diabetes mellitus using medicinal plants. Current Diabetes Reviews, 4(4), 291-308. https://doi. org/10.2174/157339908786241124 google scholar
  • Sahu, R., Ahmed, T., Sangana, R., Punde, R., &Subudhi, B. B. (2018). Effect of Tinospora cordifolia aqua-alcoholic extract on phar-macokinetic of Glibenclamide in rats: An herb-drug interaction study. Journal of Pharmaceutical and Biomedical Analysis, 151, 310-316. https://doi.org/10.1016/j.jpba.2018.01.010 google scholar
  • Sarkar, A., Tiwari, A., Bhasin, P. S., & Mitra, M. (2011). Pharmacologi-cal and pharmaceutical profile of gliclazide: A review. Journal of Applied Pharmaceutical Science, 1(9), 11-19. google scholar
  • Shaikh, A. S., Thomas, A. B., & Chitlange, S. S. (2020). Herb-drug interaction studies of herbs used in treatment of cardiovascular disorders—A narrative review of preclinical and clinical studies. Phytotherapy Research, 34(5), 1008-1026.https://doi.org/10.1002/ ptr.6585 google scholar
  • Singh, R. P., Banerjee, S., Kumar, P. V. S., Raveesha, K. A., & Rao, A. R. (2006). Tinospora cordifolia induces enzymes of carcinogen/ drug metabolism and antioxidant system, and inhibits lipid per-oxidation in mice. Phytomedicine : International Journal of Phy-totherapy and Phytopharmacology, 13(1-2), 74-84. https://doi. org/10.1016/j.phymed.2004.02.013 google scholar
  • Thikekar, A. K., Thomas, A. B., & Chitlange, S. S. (2021). Herb-drug interactions in diabetes mellitus: A review based on pre-clinical and clinical data. Phytotherapy Research, 35(9): 4763-4781. https:// doi.org/10.1002/ptr.7108 google scholar
  • Thomas, A. B., Shaikh, A. S., Raje, A., Lokhande, K. B., Swamy, K. V., Nagore, D. H., & Doke, R. (2020). Herb drug interaction of Tinos-pora cordifolia (Willd.) Miers extract and Glimepiride: In vivo and in silico studies. Medicinal Plants-International Journal of Phytomedi-cines and Related Industries, 12(4), 555-567. google scholar
  • Tsai, H.-H., Lin, H.-W., Simon Pickard, A., Tsai, H.-Y., &Mahady, G. B. (2012). Evaluation of documented drug interactions and con-traindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice, 66(11), 1056-1078. https://doi.org/10.1111/j.1742-1241.2012.03008.x google scholar
  • Wills, R. B., Bone, K., & Morgan, M. (2000). Herbal prod-ucts: active constituents, modes of action and qual-ity control. Nutrition Research Reviews, 13(1), 47-77. https://doi. org/10.1079/095442200108729007 google scholar
  • Xu, H., Williams, K. M., Liauw, W. S., Murray, M., Day, R. O., & McLach-lan, A. J. (2008). Effects of St John’s wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. British Journal of Pharmacology, 153(7), 1579-1586. https://doi. org/10.1038/sj.bjp.0707685 google scholar
  • Yao, Y., Han, W.-W., Zhou, Y.-H., Li, Z.-S., Li, Q., Chen, X.-Y., &Zhong, D.-F. (2009). The metabolism of CYP2C9 and CYP2C19 for glicla-zide by homology modeling and docking study. European Journal of Medicinal Chemistry, 44(2), 854-861. https://doi.org/10.1016/j. google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Thomas, A., Kamble, S., Chitlange, S., & Thikekar, A.K. (2022). An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats. İstanbul Journal of Pharmacy, 52(1), 31-36. https://doi.org/10.26650/IstanbulJPharm.2022.959603


AMA

Thomas A, Kamble S, Chitlange S, Thikekar A K. An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats. İstanbul Journal of Pharmacy. 2022;52(1):31-36. https://doi.org/10.26650/IstanbulJPharm.2022.959603


ABNT

Thomas, A.; Kamble, S.; Chitlange, S.; Thikekar, A.K. An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats. İstanbul Journal of Pharmacy, [Publisher Location], v. 52, n. 1, p. 31-36, 2022.


Chicago: Author-Date Style

Thomas, Asha, and Seema Kamble and Sohan Chitlange and Archana K. Thikekar. 2022. “An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats.” İstanbul Journal of Pharmacy 52, no. 1: 31-36. https://doi.org/10.26650/IstanbulJPharm.2022.959603


Chicago: Humanities Style

Thomas, Asha, and Seema Kamble and Sohan Chitlange and Archana K. Thikekar. An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats.” İstanbul Journal of Pharmacy 52, no. 1 (Apr. 2024): 31-36. https://doi.org/10.26650/IstanbulJPharm.2022.959603


Harvard: Australian Style

Thomas, A & Kamble, S & Chitlange, S & Thikekar, AK 2022, 'An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats', İstanbul Journal of Pharmacy, vol. 52, no. 1, pp. 31-36, viewed 28 Apr. 2024, https://doi.org/10.26650/IstanbulJPharm.2022.959603


Harvard: Author-Date Style

Thomas, A. and Kamble, S. and Chitlange, S. and Thikekar, A.K. (2022) ‘An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats’, İstanbul Journal of Pharmacy, 52(1), pp. 31-36. https://doi.org/10.26650/IstanbulJPharm.2022.959603 (28 Apr. 2024).


MLA

Thomas, Asha, and Seema Kamble and Sohan Chitlange and Archana K. Thikekar. An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats.” İstanbul Journal of Pharmacy, vol. 52, no. 1, 2022, pp. 31-36. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2022.959603


Vancouver

Thomas A, Kamble S, Chitlange S, Thikekar AK. An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats. İstanbul Journal of Pharmacy [Internet]. 28 Apr. 2024 [cited 28 Apr. 2024];52(1):31-36. Available from: https://doi.org/10.26650/IstanbulJPharm.2022.959603 doi: 10.26650/IstanbulJPharm.2022.959603


ISNAD

Thomas, Asha - Kamble, Seema - Chitlange, Sohan - Thikekar, ArchanaK.. An in-vivo herb-drug interaction study of Tinospora cordifolia extract on the pharmacokinetics of gliclazide in normal Wistar rats”. İstanbul Journal of Pharmacy 52/1 (Apr. 2024): 31-36. https://doi.org/10.26650/IstanbulJPharm.2022.959603



ZAMAN ÇİZELGESİ


Gönderim30.06.2021
Kabul15.02.2022
Çevrimiçi Yayınlanma28.04.2022

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.